Sander J. Robins

16.3k citations

101 papers · 12.5k indexed · 5 hit papers · h-index 46

Impact in

Endocrinology, Diabetes and Metabolism top 0.1%
- Diabetes, Cardiovascular Risks, and Lipoproteins
Cardiology and Cardiovascular Medicine top 0.5%

Papers in

Endocrinology, Diabetes and Metabolism 41
- Diabetes, Cardiovascular Risks, and Lipoproteins 30
Cardiology and Cardiovascular Medicine 29

Co-authors: Hanna E. Bloomfield Dorothea Collins Ernst J. Schaefer Ramachandran S. Vasan George M. Patton Marshall B. Elam James W. Anderson Fred H. Faas
Journals: Atherosclerosis (10 papers)Journal of Lipid Research (7 papers)The American Journal of Cardiology (6 papers)Circulation (5 papers)Arteriosclerosis Thrombosis and Vascular Biology (5 papers)
Partner nations: United States Canada Australia

In The Last Decade

Sander J. Robins

101 papers receiving 11.8k citations

Hit Papers

5 papers align trajectories log scale

Plasma Phosphatidylcholine Docosahexaenoic Acid Content and Risk of Dementia and Alzheimer Disease 2006 · 486 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2006 Archives of Neurology
2006 New England Journal of Medicine
2001 JAMA
1999 New England Journal of Medicine
1982 Journal of Lipid Research

Peers

Countries citing papers authored by Sander J. Robins

Since Specialization

Citations

This map shows the geographic impact of Sander J. Robins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sander J. Robins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sander J. Robins more than expected).

Fields of papers citing papers by Sander J. Robins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sander J. Robins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sander J. Robins. The network helps show where Sander J. Robins may publish in the future.

Co-authors

The 25 scholars most cited alongside Sander J. Robins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sander J. Robins Line = papers co-authored together Sander J. Robins links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Low-density-lipoprotein cholesterol concentrations and risk of incident diabetes: epidemiological and genetic insights from the Framingham Heart Study Diabetologia ·Charlotte Andersson, Asya Lyass, Martin G. Larson, Sander J. Robins, Ramachandran S. Vasan	2015	40
2	Red blood cell fatty acids and biomarkers of inflammation: A cross-sectional study in a community-based cohort Atherosclerosis ·João D. Fontes, Faisal Rahman, Seán Lacey, Martin G. Larson, Ramachandran S. Vasan, Emelia J. Benjamin, William S. Harris, Sander J. Robins	2015	58
3	Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study American Heart Journal ·Charlotte Andersson, Asya Lyass, Ramachandran S. Vasan, Joseph M. Massaro, Ralph B. D’Agostino, Sander J. Robins	2014	53
4	Plasma lipid transfer proteins and cardiovascular disease. The Framingham Heart Study Atherosclerosis ·Sander J. Robins, Asya Lyass, R W Brocia, Joseph M. Massaro, Ramachandran S. Vasan	2013	55
5	Changes in Erythrocyte Membrane Trans and Marine Fatty Acids between 1999 and 2006 in Older Americans Journal of Nutrition ·William S. Harris, James V. Pottala, Ramachandran S. Vasan, Martin G. Larson, Sander J. Robins	2012	96
6	Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study Atherosclerosis ·William S. Harris, James V. Pottala, Seán Lacey, Ramachandran S. Vasan, Martin G. Larson, Sander J. Robins	2012	118
7	Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease Journal of Lipid Research ·Gina M. Peloso, Serkalem Demissie, Dorothea Collins, Daniel B. Mirel, Stacey Gabriel, L. Adrienne Cupples, Sander J. Robins, Ernst J. Schaefer, Margaret E. Brousseau	2010	57
8	Contemporary Trends in Dyslipidemia in the Framingham Heart Study Archives of Internal Medicine ·Erik Ingelsson, Joseph M. Massaro, Patrice Sutherland, Paul F. Jacques, Daniel Levy, Ralph B. D’Agostino, Ramachandran S. Vasan, Sander J. Robins	2009	34
9	Long-term C-Reactive Protein Variability and Prediction of Metabolic Risk The American Journal of Medicine ·Ting-hsu Chen, Philimon Gona, Patrice Sutherland, Emelia J. Benjamin, Peter W.F. Wilson, Martin G. Larson, Ramachandran S. Vasan, Sander J. Robins	2008	22
10	Codon 54 polymorphism of the fatty acid binding protein (FABP) 2 gene is associated with increased cardiovascular risk in the dyslipidemic diabetic participants of the veterans affairs HDL intervention trial (VA-HIT) Atherosclerosis ·Angeliki Georgopoulos, Hanna E. Bloomfield, Dorothea Collins, Margaret E. Brousseau, José M. Ordovás, John O’Connor, Sander J. Robins, Julieta Fortino	2006	20
11	Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death New England Journal of Medicine ·Thomas J. Wang, Philimon Gona, Martin G. Larson, Geoffrey H. Tofler, Daniel Levy, Christopher Newton‐Cheh, Paul F. Jacques, Nader Rifai, Jacob Selhub, Sander J. Robins, Emelia J. Benjamin, Ralph B. D’Agostino, Ramachandran S. Vasan Hit paper breakdown →	2006	976
12	PPAR Ligands and Clinical Trials: Cardiovascular Risk Reduction with Fibrates European Journal of Cardiovascular Prevention & Rehabilitation ·Sander J. Robins	2001	18
13	Effect of ursodeoxycholic acid on hepatic LDL binding and uptake in dietary hypercholesterolemic hamsters Atherosclerosis ·Susan Ceryak, Bernard Bouscarel, M Malavolti, Sander J. Robins, Meylin Rosa Aphang Lam, Hans Fromm	2000	5
14	Delineation of A Novel Hepatic Route for the Selective Transfer of Unesterified Sterols From High–Density Lipoproteins to Bile: Studies Using the Perfused Rat Liver Hepatology ·Sander J. Robins, Joan M. Fasulo	1999	34
15	Influence of risk factors on peripheral and cerebrovascular disease in men with coronary artery disease, low high-density lipoprotein cholesterol levels, and desirable low-density lipoprotein cholesterol levels American Heart Journal ·Vasilios Papademetriou, Puneet Narayan, Hanna E. Bloomfield, Dorothea Collins, Sander J. Robins	1998	24
16	The veterans affairs high-density lipoprotein intervention trial: Baseline characteristics of normocholesterolemic men with coronary artery disease and low levels of high-density lipoprotein cholesterol The American Journal of Cardiology ·Hanna E. Bloomfield, Sander J. Robins, Dorothea Collins	1996	46
17	Distribution of lipids in 8,500 men with coronary artery disease The American Journal of Cardiology ·Hanna E. Bloomfield, Sander J. Robins, Dorothea Collins, Ali Iranmanesh, Timothy J Wilt, Douglas L. Mann, Michael F. Mayo‐Smith, Fred H. Faas, Marshall B. Elam, Gale H. Rutan, James W. Anderson, Moti L. Kashyap, Gordon Schectman	1995	190
18	Gender differences in the development of hyperlipemia and atherosclerosis in hybrid hamsters Metabolism ·Sander J. Robins, Joan M. Fasulo, George M. Patton, Ernst J. Schaefer, Donald E. Smith, José M. Ordovás	1995	25
19	Rationale and design of the Department of Veterans Affairs high-density lipoprotein cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol The American Journal of Cardiology ·Hanna E. Bloomfield, Sander J. Robins, Marika K. Iwane, William E. Boden, Marshall B. Elam, Carol L. Fye, David J. Gordon, Ernst J. Schaefer, Gordon Schectman, Janet Wittes	1993	81
20	The transport of lipoprotein cholesterol into bile: a reassessment of kinetic studies in the experimental animal Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Sander J. Robins, Joan M. Fasulo, Raymond Leduc, George M. Patton	1989	27

About Sander J. Robins

Sander J. Robins is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Nutrition and Dietetics, Surgery and Biochemistry, having authored 101 papers that have together received 12.5k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (34 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (30 papers), Cholesterol and Lipid Metabolism (15 papers), Drug Transport and Resistance Mechanisms (14 papers), Fatty Acid Research and Health (13 papers), Liver Disease Diagnosis and Treatment (12 papers), Peroxisome Proliferator-Activated Receptors (11 papers) and Metabolomics and Mass Spectrometry Studies (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.9k citations), Cardiology and Cardiovascular Medicine (2.8k citations), Surgery (5.4k citations), Biochemistry (742 citations) and Nutrition and Dietetics (1.5k citations). Sander J. Robins has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Hanna E. Bloomfield, Dorothea Collins, Ernst J. Schaefer, Ramachandran S. Vasan, George M. Patton, Marshall B. Elam, James W. Anderson, Fred H. Faas, J M Fasulo and Gordon Schectman. Their work appears in journals such as Atherosclerosis, Journal of Lipid Research, The American Journal of Cardiology, Circulation and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact